A5004834248- HIV, Drug Use, Sexual Risk
- HIV/AIDS Research and Interventions
- Criminal Justice and Corrections Analysis
- Hepatitis C virus research
- Homelessness and Social Issues
- Hepatitis B Virus Studies
- Adolescent Sexual and Reproductive Health
- Liver Disease Diagnosis and Treatment
- Sex work and related issues
- HIV Research and Treatment
- SARS-CoV-2 detection and testing
- Health Policy Implementation Science
- Viral Infections and Outbreaks Research
- Ethics in Clinical Research
- Psychopathy, Forensic Psychiatry, Sexual Offending
- COVID-19 epidemiological studies
- Reproductive tract infections research
- Advanced Causal Inference Techniques
- Healthcare Decision-Making and Restraints
- Influenza Virus Research Studies
- Food Security and Health in Diverse Populations
- COVID-19 and healthcare impacts
- Tuberculosis Research and Epidemiology
- Vaccine Coverage and Hesitancy
- Opioid Use Disorder Treatment
Emory University
2016-2025
Albert Einstein College of Medicine
2023-2024
Emory and Henry College
2023-2024
Target (United States)
2023
Rapt Therapeutics (United States)
2021
Morehouse School of Medicine
2018
Brown University
1998-2015
Fulton County Medical Examiner's Office
2014
Elton John AIDS Foundation
2014
Bristol-Myers Squibb (Germany)
2014
Because certain groups at high risk for HIV/AIDS (human immunodeficiency virus/acquired syndrome) come together in correctional facilities, seroprevalence was early the epidemic. The share of epidemic borne by inmates and persons released from jails prisons United States (US) 1997 estimated a previous paper. While number releasees has risen, their HIV rates have fallen. We sought to determine if US decreased between 2006. created new model population flow out facilities estimate In 1997,...
Flattening the Curve for Incarcerated Populations People caught up in U.S. justice system have already been affected by SARS-CoV-2, and improved preparation is essential to minimizing impac...
The life expectancy of persons cycling through the prison system is unknown. authors sought to determine 15.5-year survival 23,510 imprisoned in state Georgia on June 30, 1991. After linking and mortality records, they calculated standardized ratios (SMRs). cohort experienced 2,650 deaths during follow-up, which were 799 more than expected (SMR = 1.43, 95% confidence interval (CI): 1.38, 1.49). Mortality incarceration was low 0.85, CI: 0.77, 0.94), while postrelease high 1.54, 1.48, 1.61)....
In the United States, 10 million inmates are released every year, and human immunodeficiency virus (HIV) infection acquired syndrome (AIDS) prevalence is several-fold greater in criminal justice populations than community. Few effective linkage-to-the-community programs currently available for prisoners infected with HIV. As a result, combination antiretroviral therapy (cART) seldom continued after release, virological immunological outcomes worsen. Poor HIV treatment result from myriad of...
The prevalence of hepatitis C virus (HCV) in U.S. prisoners is high; however, HCV testing and treatment are rare. Infected inmates released back into society contribute to the spread general population. Routine screening followed by new therapies may reduce ongoing transmission.To evaluate health economic effect prisons on epidemic society.Agent-based microsimulation model transmission progression disease.Published literature.Population community.30 years.Societal.Risk-based universal...
Preventing coronavirus disease 2019 (COVID-19) in correctional and detention facilities* can be challenging because of population-dense housing, varied access to hygiene facilities supplies, limited space for isolation quarantine (1). Incarcerated detained populations have a high prevalence chronic diseases, increasing their risk severe COVID-19-associated illness making early detection critical (2,3). Correctional are not closed systems; SARS-CoV-2, the virus that causes COVID-19,...
Objectives. Although the hepatitis C epidemic in United States disproportionately affects correctional populations, last national estimates of seroprevalence and disease burden among these populations are more than a decade old. We investigated routine surveillance conducted state prison systems updated previous estimates. Methods. surveyed all U.S. departments to determine which had performed screening since 2001. Using data for systems, we estimated prisoners 2006 share borne by...
Background: Approximately 1 in 4 of the nearly 2 million individuals state and federal correctional facilities are infected with hepatitis C virus (HCV). Currently, there few reports treatment outcomes this common infection setting. Objective: To describe HCV therapy incarcerated Design: Retrospective, descriptive observational study. Setting: Rhode Island Department Corrections, Cranston, Island. Patients: 93 inmates chronic infection. Intervention: Interferon- ribavirin. Measurements: RNA...
This paper describes the means by which a United States National Institute on Drug Abuse (NIDA)-funded cooperative, Juvenile Justice-Translational Research Interventions for Adolescents in Legal System (JJ-TRIALS), utilized an established implementation science framework conducting multi-site, multi-research center intervention initiative. The initiative aimed to bolster ability of juvenile justice agencies address unmet client needs related substance use while enhancing inter-organizational...
The policies of mass incarceration and the expansion criminal justice system in USA over last 40 years have weighed heavily on individuals communities impacted by drug use HIV disease. Though less than ideal, jails provide a unique opportunity to diagnose, treat implement effective interventions. role detection, treatment, continuity care, however, has yet be systematically examined. This paper reviews service strategies contexts for 10 demonstration sites funded develop innovative methods...
We sought to develop a detailed description of the variety jail release patterns and learn what factors affect length stay (LOS).The main data set for study came from biennial Bureau Justice Statistics survey on felony defendants in large urban counties.The median LOS was 7 days. One quarter jails had less than 2 days; 75% 15 Median regression showed that male gender, previous arrests, violent charges were predictive longer LOS.The diversity among has not been previously described. A public...
Screening and treating correctional populations for HIV HCV infections is essential to successfully addressing both epidemics in the USA. The prevalence of infection high prisons jails due increased rates incarceration among disproportionately affected groups such as injection drug users. Through a search published grey literature surveying persons overseeing health programs prisons, we collected data on efforts determine first then HCV. Prevalence varies geographically temporally,...
Summary Background The hepatitis C virus (HCV) care cascade has changed dramatically following the introduction of direct‐acting anti‐virals (DAAs). Up‐to‐date estimates are needed to monitor progress, identify key gaps and inform policy. Aim To estimate current future HCV in United States, nationally select subpopulations interest. Methods We used a previously validated mathematical model simulate landscape States from 2011 onwards, accounting for screening policy updates, newer treatments...
Airborne pathogens present challenges in settings like jails or prisons with a high density of contacts. The state Georgia has the highest percentage its citizens under correctional supervision United States. Yet, it had slow COVID vaccine uptake among jail residents, requiring prevention also using non-pharmaceutical interventions. Using network-based SARS-CoV-2 transmission model parameterized data from Fulton County Jail, this study investigates impact three strategies: vaccination,...